Enlargement of the Spleen Index Is a Predictor of the Occurrence of Esophageal Varices and Hepatocellular Carcinoma after Administering Direct-acting Antiviral Agents-Reference-Cited by-同舟云学术

Enlargement of the Spleen Index Is a Predictor of the Occurrence of Esophageal Varices and Hepatocellular Carcinoma after Administering Direct-acting Antiviral Agents

Published:2023-09-15 Issue:18 Volume:62 Page:2597-2606
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Furuichi Yoshihiro¹,Fujiwara Tomoyuki²,Shimojima Rieko²,Sato Koichiro²,Kato Hiroyuki²

Affiliation:

1. Department of Gastroenterology and Hepatology, Tokyo Medical University, Japan

2. Department of Clinical Laboratory and Endoscopy, Tokyo Women's Medical University Adachi Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/18/62_1166-22/_pdf

Reference26 articles.

1. 1. Villani R, Monami M, Di Cosimo F, et al. Direct-acting antivirals for HCV treatment in older patients: a systematic review and meta-analysis. J Viral Hepat 26: 1249-1256, 2019.

2. 2. Tosetti G, Degasperi E, Farina E, et al. Decompensation in direct-acting antiviral cured hepatitis C virus compensated patients with clinically significant portal hypertension: too rare to warrant universal B-blocker therapy. Am J Gastroenterol 116: 1342-1344, 2021.

3. 3. Nagaoki Y, Imamura M, Teraoka Y, et al. Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients. Hepatol Res 50: 1222-1233, 2020.

4. 4. Knop V, Hoppe D, Vermehren J, et al. Noninvasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study. J Viral Hepat 28: 1604-1613, 2021.

5. 5. Furuichi Y, Moriyasu F, Taira J, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol 48: 1061-1068, 2013.